Short answer
Cannabis does not treat multiple sclerosis or slow it. Trial data support its use for some symptoms, mostly spasticity and central pain. A regimen is a fixed set of products, amounts, timing, and a way to score results. Start low, raise on a schedule, and keep records so you and your clinician can see what works.
What the evidence covers
A Cochrane review of randomized trials found moderate-quality evidence that oral cannabis extract lowers spasticity and pain in MS. Evidence for smoked or vaped flower is weaker. Most trials used oral extracts or synthetic THC, sold as nabilone and dronabinol.
Cannabis for Multiple Sclerosis Research
The National Multiple Sclerosis Society lists cannabis as an option for spasticity, pain, and sleep problems, and notes limits in the data. The National Institute of Neurological Disorders and Stroke states that MS has no cure.
Cannabis for MS Neuropathy: What the Evidence Says
Spasticity
Nabiximols (Sativex) is a mouth spray with THC and CBD. It is approved for MS spasticity in Canada, the UK, and other countries. The US Food and Drug Administration has not approved it. In US practice, clinicians use dronabinol or nabilone off label.
cannabis ms treatment effectiveness
Pain and sleep
Trials report drops in central neuropathic pain and better sleep. Sleep gains often follow pain and spasm control. CBD alone has less trial support for MS spasticity than THC products.
Bladder and tremor
Data are thin. Small studies look at bladder urgency. Tremor studies show mixed results. Treat these as open questions.
Forms
- Oral extract or oil: dose in milligrams of THC and CBD. Slow onset, 1 to 3 hours. Duration 6 to 8 hours.
- Capsules: same as oil, fixed dose.
- Oromucosal spray: 2.5 mg THC plus 2.5 mg CBD per spray in the nabiximols formula.
- Inhaled flower or vape: onset in minutes, duration 1 to 3 hours. Harder to dose.
- Topicals: no psychoactive effect. Data for MS pain are limited.
How to build a regimen
- Set one target symptom: spasticity, pain, or sleep. One at a time.
- Score it before you start. Rate 0 to 10 each night.
- Pick one product and hold the form constant.
- Start at 2.5 mg THC or less. Take it at the same time each day.
- Hold the dose for 3 to 7 days. Then raise by 2.5 mg if the score has not moved.
- Stop at the dose that helps. Do not chase a high.
- Log dose, time, score, and side effects.
- Review at 4 to 8 weeks with the clinician who manages your MS.
Risks and interactions
Side effects include dizziness, dry mouth, fatigue, memory problems, and fast heart rate. Falls are a real risk for people with gait problems. Cannabis adds to the sedative effect of baclofen, tizanidine, benzodiazepines, opioids, and alcohol. THC raises heart rate in some people. Start lower if you are over 65 or take a sedative. Do not drive after THC. Avoid cannabis in pregnancy. Some data link heavy use to cognitive effects in people who already have MS-related cognitive changes.
US legal notes
Cannabis is Schedule I under federal law. States run their own medical programs. A state medical card needs a certifying provider and, in most states, a fee. Amounts, product types, and possession limits differ by state. In states with adult-use programs, adults 21 and over can buy without a card, but taxes and limits differ.
What cannabis does not do
It does not replace disease-modifying therapy. It does not repair myelin. It does not stop relapses. Keep every DMT and rehab appointment. Tell your neurologist about every cannabis product, including CBD bought online, because labels are often wrong.